首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Basic Studies on Formulation, Method of Preparation and Characterization of Water-in-Oil-in-Water Type Multiple Emulsions Containing Vancomycin
【24h】

Basic Studies on Formulation, Method of Preparation and Characterization of Water-in-Oil-in-Water Type Multiple Emulsions Containing Vancomycin

机译:含万古霉素的水包油包水型多乳化液的配制,制备方法和表征的基础研究

获取原文
获取原文并翻译 | 示例
       

摘要

A method of preparing a stable water-in-oil-in-water type multiple emulsion (w/o/w emulsion) as a carrier of peptides was sought by studying rotation rate of homogenizer, mixing ratio of each component and concentrations of surfactants. We used "Lipiodol Ultra-Fluid? and isoropyl myristate oil mixture (4.5:5.5)" for an oil phase of the w/o/w emulsion to minimize the difference in specific gravity between this phase and an aqueous phase and to reduce the viscosity of the former, w/o/w emulsions entrapping vancomycin hydrochloride in their internal aqueous phases were prepared by a modified two-stage enmlsificntion procedure and their particle size, entrapment efficiency, viscosity, separation and drug release property studied. The particle size of the w/o/w emulsion was smaller with an increase in rotation rate at an emulsification stage (96.3 + 31.8 ftm at lOOOrpm and 2.81±1.37/im at 20000rpm), but its entrapment efficiency was slightly reduced with rate increase. The best mixing ratio of internal aqueous phase:oil phase:external aqueous phase was 1:4:5. For surfactants, HCO-40 (5% (w/v)) and Phironic F-88 (5% (w/v)) were dissolved in the oily and the external aqueous phase, respectively. Drug release from the w/o/w emulsion was extremely slow and sustained, and that property tended to be faster with a decrease in their particle size (0% at 96.3/im and 2.97 + 0.41% at 2.81 fim). The stability of w/o/w emulsion of 10 fim diameter was good from observations of optical and scanning electron microphotographs and measurement of w/o/w emulsion diameters. The w/o/w emulsion prepared in this study is viewed as a possible carrier of water-soluble drugs.
机译:通过研究均化器的旋转速度,各组分的混合比和表面活性剂的浓度,寻求一种制备稳定的水包油包水型多元乳液(w / o / w乳液)作为肽载体的方法。我们将“ Lipiodol Ultra-Fluid?和异丙基肉豆蔻酸酯油混合物(4.5:5.5)”用于w / o / w乳液的油相,以最大程度地减少该相与水相之间的比重差并降低粘度通过改进的两阶段Enmlsificnization程序制备前者的w / o / w乳剂,在其内部水相中截留盐酸万古霉素,并研究了它们的粒径,包封率,粘度,分离和药物释放性能。 w / o / w乳液的粒径随着乳化阶段旋转速率的增加而变小(在100rpm时为96.3 + 31.8 ftm,在20000rpm时为2.81±1.37 / im),但随着速率的增加,其包封率略有降低。 。内部水相:油相:外部水相的最佳混合比为1:4:5。对于表面活性剂,分别将HCO-40(5%(w / v))和Phironic F-88(5%(w / v))溶解在油相和外部水相中。从w / o / w乳剂中释放的药物非常缓慢且持续,并且随着粒径的减小,该特性趋于更快(96.3 / im为0%,2.81 fim为2.97 + 0.41%)。通过观察光学和扫描电子显微照片以及测量w / o / w乳剂直径,w / o / w乳剂直径为10μm的稳定性良好。在这项研究中制备的w / o / w乳剂被视为水溶性药物的可能载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号